No Data
Express News | Cutia Therapeutics - CEO Purchased Total of 8,000 Shares on 9 and 10 October for HK$102,816
Consumer Electronics - B (02487.HK) spent 0.2562 million Hong Kong dollars on repurchasing 0.0188 million shares on October 8th.
Gelonghui October 9th | Ke Di - B (02487.HK) announced that on October 8, 2024, it spent 0.2562 million Hong Kong dollars to repurchase 0.0188 million shares at a repurchase price of 12.32-15.18 Hong Kong dollars per share.
Cutia Therapeutics CFO Purchases Shares; Shares Plummet 21%
[Hong Kong Stock Connect] Ke Di (02487) recently received an increase in shareholding of 0.05 million shares from Chief Financial Officer Huang Yuqing, involving approximately 0.7477 million Hong Kong dollars.
Kim Eng's financial news | Gland Pharma (02487) announced that they received a notification from the company's Chief Financial Officer and Executive Director, Huang Yuqing, stating that on October 2 and 3, 2024, he purchased a total of 0.05 million shares on the open market with personal funds, at a total cost of approximately 0.7477 million Hong Kong dollars, equivalent to an average price of approximately 14.954 Hong Kong dollars per share.
Express News | Cutia Therapeutics - Increase in Shareholding by Chief Financial Officer and Executive Director
Cutia Therapeutics' Enrolled Patients Completes Phase II Clinical Trial for Metabolic Disease Drug
No Data
No Data